Alport Syndrome: Causes, Symptoms & Treatment in Canada

Alport syndrome is a rare genetic condition that progressively damages the kidneys, hearing, and vision, and it affects thousands of families across Canada. Also known as hereditary nephritis, this inherited disorder accounts for less than 1% of all end-stage kidney disease cases in the country, yet its impact on daily life can be profound. Early diagnosis and ongoing management are essential for slowing its progression.

How Alport Syndrome Affects the Kidneys, Ears, and Eyes

Understanding the causes, symptoms, and treatment options for this type IV collagen disorder can help Canadian patients and their families take timely action. Whether you have a family history of genetic kidney disease or are experiencing unexplained blood in your urine and hearing changes, this guide covers everything you need to know — including when to speak with your family doctor or visit a walk-in clinic.

What Is Alport Syndrome?

Types of Alport Syndrome: Characteristics and Management

Type	Genetic Pattern	Key Characteristics	Management Approach
X-Linked Alport Syndrome (XLAS)	Mutation in COL4A5 gene on X chromosome; accounts for ~80% of Alport syndrome cases	Males typically experience faster progression to kidney failure (often by age 30–40); females may have milder symptoms including microscopic hematuria and proteinuria	ACE inhibitors or ARBs to reduce proteinuria; regular nephrology follow-up; kidney transplant evaluation when approaching end-stage renal disease
Autosomal Recessive Alport Syndrome (ARAS)	Mutations in both copies of COL4A3 or COL4A4 genes; affects males and females equally	Similar severity in both sexes; kidney failure typically occurs before age 30; hearing loss and eye abnormalities commonly present	Early initiation of renin-angiotensin system (RAS) blockade; audiology and ophthalmology referrals; genetic counselling for family planning
Autosomal Dominant Alport Syndrome (ADAS)	Single mutation in COL4A3 or COL4A4; accounts for ~20% of non-X-linked cases	Generally milder progression; kidney failure often occurs later in life (50s–60s); hematuria is a consistent finding; hearing loss may be less severe	Blood pressure management; ACE inhibitors; regular urinalysis and kidney function monitoring; lifestyle modifications including low-sodium diet
Thin Basement Membrane Nephropathy (TBMN)	Heterozygous mutation in COL4A3 or COL4A4; considered part of the Alport syndrome spectrum	Persistent microscopic hematuria with minimal proteinuria; kidney function usually preserved; rarely progresses to kidney failure; no hearing or vision involvement	Watchful waiting with annual monitoring of blood pressure, urinalysis, and kidney function; patient education about signs of disease progression
Alport Syndrome with Diffuse Leiomyomatosis	Deletion affecting COL4A5 and COL4A6 genes; rare subtype	Benign smooth muscle tumours in the oesophagus, tracheobronchial tree, and female genitalia in addition to typical kidney, hearing, and eye involvement	Multidisciplinary care involving nephrology, gastroenterology, and surgery; standard kidney-protective therapies; monitoring for leiomyoma-related complications

Alport syndrome is a hereditary kidney disorder first described in 1927. A doctor studying three generations of one family noticed they all suffered from progressive kidney disease and hearing loss. Since then, researchers have learned a great deal about the condition.

The syndrome affects a protein called type IV collagen. This protein is a key building block of the basement membrane — a thin, sheet-like structure that supports and separates tissues in the kidneys, ears, and eyes. When the collagen does not form correctly, these structures stop working properly.

Approximately 40% of people with Alport syndrome develop end-stage kidney disease by age 40. Early detection makes a real difference. For more background on kidney disease in Canada, visit Health Canada’s official health resources.

What Causes Alport Syndrome?

Alport syndrome is caused by mutations — or errors — in the genes that produce type IV collagen. There are three genetic forms of the condition. Each form affects different gene pairs and follows a different pattern of inheritance.

The Three Genetic Forms

• X-linked Alport syndrome (XLAS): This is the most common form, making up more than 85% of all cases. It results from a mutation in the gene that produces the alpha-5 chain of type IV collagen. This gene sits on the X chromosome.
• Autosomal recessive Alport syndrome (ARAS): This form accounts for 10–15% of cases. It involves mutations in the genes that produce the alpha-3 or alpha-4 chains. Both parents must carry the faulty gene for a child to develop this form.
• Autosomal dominant Alport syndrome (ADAS): This is the rarest form. It also involves mutations in the alpha-3 or alpha-4 chain genes, but only one copy of the faulty gene is needed to cause the condition.

These genetic mutations interfere with how collagen is built and used in the body. As a result, the basement membranes in the kidneys, inner ear, and eyes cannot function normally. The kidneys lose their ability to filter waste from the blood properly. Over time, this leads to scarring of kidney tissue and, eventually, kidney failure.

How Alport Syndrome Affects the Body

The kidneys act like a filter. They remove waste products and excess fluid from the blood and turn them into urine. In Alport syndrome, the damaged basement membrane allows blood cells and proteins to leak into the urine. This is one of the earliest and most important signs of the condition.

Kidney Symptoms

Hematuria (blood in the urine) is the most common and earliest symptom of Alport syndrome. In boys, blood in the urine can appear as early as the first year of life. In fact, researchers believe that if a child with a family history does not show hematuria in that first year, Alport syndrome is unlikely.

Hematuria may be microscopic — meaning only visible under a microscope — or macroscopic, where the urine appears pink or red. It is persistent in males but tends to come and go in females. Infections of the upper respiratory tract, like a common cold, can trigger episodes of visible blood in the urine in about 70% of patients.

Proteinuria (protein in the urine) often develops later. It is usually absent in childhood but appears in adult males with the X-linked form and in both males and females with the autosomal recessive form. High blood pressure (hypertension) is also a common feature and tends to worsen as the kidneys decline.

Hearing Symptoms

Hearing loss in Alport syndrome does not appear at birth. Instead, it develops gradually during childhood or adolescence. It always shows up before kidney failure becomes severe. The hearing loss typically affects high-frequency sounds first and may progress to require hearing aids.

Eye Symptoms

Some people with Alport syndrome develop eye abnormalities. The most recognisable is anterior lenticonus — an unusual forward bulging of the eye lens. This can cause blurry vision and may be spotted during a routine eye exam. Like hearing changes, eye problems never appear at birth.

Who Is Most at Risk?

Because Alport syndrome is genetic, it runs in families. Anyone with a parent or sibling diagnosed with hereditary nephritis or unexplained kidney disease combined with hearing loss should speak to their family doctor about genetic screening. The condition occurs in roughly 1 in every 5,000 people.

Males with the X-linked form tend to experience more severe symptoms than females. This is because males have only one X chromosome. Females with one affected X chromosome often have milder symptoms, though they can still develop kidney problems and hearing loss over time. Both males and females with the autosomal recessive form are equally affected.

For a broader understanding of how genetics influence kidney disease, the Mayo Clinic’s kidney disease resources offer clear and reliable information.

Diagnosing Alport Syndrome

Diagnosing Alport syndrome usually begins with a urine test. A simple dipstick test at your family doctor’s office or walk-in clinic can detect blood or protein in the urine. If either is found, further testing follows.

Common Diagnostic Tests

• Urine microscopy: A lab examines a urine sample under a microscope to look for red blood cells.
• Blood tests: These check how well the kidneys are filtering waste. A measurement called creatinine reflects kidney function.
• Kidney biopsy: A small sample of kidney tissue is examined under a specialised electron microscope. In Alport syndrome, the basement membrane shows a distinctive irregular, layered appearance — sometimes described as a basket-weave pattern.
• Genetic testing: This can confirm the specific mutation involved and identify the form of Alport syndrome. It is increasingly available through provincial health programmes.
• Hearing test (audiogram): This checks for high-frequency hearing loss, which is common in the condition.
• Eye examination: An ophthalmologist can spot lens abnormalities linked to Alport syndrome.

In Canada, your family doctor can refer you for these tests through your provincial health plan. Early diagnosis is important because it allows for closer monitoring and earlier treatment to slow kidney damage.

Managing Alport Syndrome

There is currently no cure for Alport syndrome. However, treatments can slow the progression of kidney damage significantly. Managing blood pressure is one of the most important steps. Medications called ACE inhibitors or ARBs are commonly prescribed. These drugs lower blood pressure and reduce protein leaking from the kidneys, which helps preserve kidney function longer.

In cases where the kidneys fail completely, dialysis or a kidney transplant becomes necessary. Kidney transplants generally work well in people with Alport syndrome. Hearing aids can manage hearing loss effectively. Regular follow-up with a nephrologist (kidney specialist) is essential.

Lifestyle changes also play a role. Staying well hydrated, following a kidney-friendly diet, avoiding smoking, and maintaining a healthy weight all support kidney health. Your healthcare team can guide you on the best approach for your situation. For additional information on kidney health strategies, Healthline’s kidney health section provides accessible and evidence-based guidance.

When to See a Doctor

You should contact your family doctor if you notice blood in your urine, even once. This is true even if it disappears quickly. Blood in the urine is never normal and always deserves investigation. If your family doctor is unavailable, a walk-in clinic can do an initial urine test and refer you for further care.

You should also see a doctor if you have a family history of kidney disease paired with hearing loss, or if your child’s routine urine test shows abnormal results. Early action can make a real difference in preserving kidney function over time. Provincial health plans across Canada cover the initial assessments needed to begin a diagnosis.

Always speak with a qualified healthcare provider before making any decisions about your health or treatment. This article is for general information only and does not replace professional medical advice.

Frequently Asked Questions About Alport Syndrome

Key Takeaways

• Alport syndrome is a rare genetic condition that damages the kidneys, hearing, and vision.
• It is caused by mutations in the genes that build type IV collagen, a protein essential to kidney function.
• The most common early symptom is blood in the urine, which can appear in infancy in boys.
• Hearing loss and eye changes develop during childhood or adolescence, before kidney failure sets in.
• About 40% of patients develop end-stage kidney disease by age 40.
• There is no cure, but blood pressure medications can slow the progression of kidney damage.
• Early diagnosis through your family doctor or walk-in clinic is key to better outcomes.
• Genetic testing is available through provincial health programmes for at-risk families.
• Always consult a qualified healthcare provider for diagnosis and treatment specific to your situation.